Know Cancer

or
forgot password

Optimizing the Use of Entonox® During Screening Colonoscopy: an Open Randomised Controlled Trial


Phase 4
60 Years
75 Years
Open (Enrolling)
Both
Bowel Cancer Screening, Analgesia, Entonox, Colonoscopy

Thank you

Trial Information

Optimizing the Use of Entonox® During Screening Colonoscopy: an Open Randomised Controlled Trial


Inclusion Criteria:



- Having a bowel cancer screening programme colonoscopy

Exclusion Criteria:

- Contraindications to Entonox

- Previous bowel resections

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Outcome Measure:

Pain scores

Outcome Description:

Patients will be asked about their overall recollection of pain on a 10 point numerical ratings scale prior to discharge

Outcome Time Frame:

Day 1: Prior to discharge from endoscopy department

Safety Issue:

No

Principal Investigator

Stuart A Riley, MB ChB

Investigator Role:

Principal Investigator

Investigator Affiliation:

Sheffield Teaching Hospital

Authority:

United Kingdom: Medicines and Healthcare Products Regulatory Agency

Study ID:

STH16359

NCT ID:

NCT01865721

Start Date:

January 2013

Completion Date:

September 2013

Related Keywords:

  • Bowel Cancer Screening
  • Analgesia
  • Entonox
  • Colonoscopy
  • Bowel cancer screening
  • Analgesia
  • Entonox
  • Pain
  • Side effects
  • Colonoscopy
  • Intestinal Neoplasms

Name

Location